Beyond Medications: Deep Brain Stimulation (DBS) and Surgery
At a Glance
For severe early-onset generalized dystonia that remains disabling despite treatment, deep brain stimulation (DBS) may improve movement and quality of life. Candidacy depends on the genetic cause, ability to walk, fixed contractures, surgical risks, and long-term programming and battery care.
When medications and botulinum toxin injections no longer provide enough relief, your neurology team may discuss an early referral for Deep Brain Stimulation (DBS) evaluation. While the thought of brain surgery is daunting, for many with severe generalized dystonia, DBS can significantly improve quality of life and physical function [1]. Candidacy does not mean a person must fail every single medication before referral; treatable causes (like DRD) should be addressed first, but timing for DBS depends on etiology, age, mobility, fixed deformity, and the goals of the patient.
What is DBS?
DBS is often described as a “pacemaker for the brain.” It involves a surgical procedure where thin, insulated wires called leads are placed into a specific part of the brain called the Globus Pallidus internus (GPi) [2]. These leads are connected to a small device called an implantable pulse generator (IPG)—the “battery”—usually placed under the skin near the collarbone or in the abdomen [3].
The device sends high-frequency electrical pulses to the brain. This doesn’t “fix” the brain’s wiring, but it helps block or override the abnormal, disorganized signals that cause dystonia [2]. By normalizing these signals, DBS helps the brain’s movement networks function more smoothly [4][5].
When is DBS Considered?
DBS is typically considered for individuals with medically refractory dystonia. This means the dystonia is causing significant disability and has not responded well to appropriate medications or botulinum toxin [1][6].
Timing is individualized, but discussing surgery before the loss of ambulation or the development of fixed contractures (where muscles and tendons permanently shorten) is often recommended, as DBS cannot reverse fixed bone or joint deformities [7][8][9].
Expectations Based on Genetic Cause
The underlying cause is one of the best predictors of how well DBS will work, though response varies substantially from person to person.
- TOR1A (DYT1): Individuals with this genetic subtype often have a robust response. Group averages from observational cohorts show an improvement in motor scores of approximately 70% to 76% after one year [10][7].
- KMT2B: Outcomes for KMT2B are more heterogeneous. Group averages from observational cohorts show more modest motor improvements, around 33% to 42% [10][11]. While DBS may help preserve the ability to walk and improve dystonic speech, an underlying learning or developmental disability would not be expected to reverse [11].
(Note: These figures are group averages from observational cohorts based on specific motor scales, not a guaranteed prediction for an individual’s walking, speech, or pain.)
Risks of Brain Surgery and DBS
Before proceeding, families must have a balanced explanation of the material risks involved [12].
- Surgical Risks: Include intracranial hemorrhage (bleeding in the brain), stroke, seizure, anesthesia complications, and infection.
- Stimulation Risks: Adjustments to the electrical pulses can sometimes cause speech, balance, mood, or cognitive side effects.
- Hardware Complications: Lead misplacement, dislocation as a child grows, wire breakage, or infections that may require revision surgery. Center-specific complication rates vary [3][12].
Life with a DBS System
DBS requires a long-term commitment to care from an experienced multidisciplinary team [1][13].
- Programming: After surgery, the device must be “programmed.” A specialist will adjust the electrical settings to find the best balance between symptom relief and side effects [14].
- Delayed Benefit: Full benefit of DBS is not always immediate. Some symptoms can take months of gradual adjustments to show significant change [15][16].
- Battery Maintenance: The battery (IPG) will eventually need to be replaced in a minor surgical procedure. While rechargeable systems last longer, their longevity depends on the device model, stimulation settings, charging practice, and battery status [14]. Ask your team exactly what to do if charging fails or symptoms return unexpectedly.
Common questions in this guide
How can deep brain stimulation help early-onset generalized dystonia?
When should a child with generalized dystonia be evaluated for DBS?
Does the genetic cause affect how well DBS works?
What are the risks of DBS surgery for dystonia?
What ongoing care is needed after DBS surgery?
Can DBS reverse fixed contractures or developmental disabilities?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Early-onset generalized dystonia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my child meet the criteria for 'medically refractory' dystonia, and which specific medication trials have we ruled out?
- 2.Based on the genetic subtype (like TOR1A or KMT2B), what is the realistic expected improvement in motor scores and daily function?
- 3.What are the risks of hardware complications like infection or lead breakage specifically for an active person?
- 4.How frequently will we need to visit the clinic for programming adjustments in the first year after surgery?
- 5.Is our surgical team experienced with early-onset dystonia, and do they include a multidisciplinary team for long-term follow-up?
- 6.For the specific battery model proposed, what is the expected lifespan and what happens if it fully depletes?
References
References (16)
- 1
Childhood dystonias.
Tabbal SD
Current treatment options in neurology 2015; (17(3)):339 doi:10.1007/s11940-015-0339-4.
PMID: 25704239 - 2
Common therapeutic mechanisms of pallidal deep brain stimulation for hypo- and hyperkinetic movement disorders.
McCairn KW, Iriki A, Isoda M
Journal of neurophysiology 2015; (114(4)):2090-104 doi:10.1152/jn.00223.2015.
PMID: 26180116 - 3
Long-term results of deep brain stimulation in a cohort of eight children with isolated dystonia.
Krause P, Lauritsch K, Lipp A, et al.
Journal of neurology 2016; (263(11)):2319-2326 doi:10.1007/s00415-016-8253-6.
PMID: 27567612 - 4
Acute and Chronic Local Field Potential Recordings in Dystonia-A Systematic Review.
Horan J, Donlon E, Gill A, et al.
Movement disorders clinical practice 2026; doi:10.1002/mdc3.70744.
PMID: 42494087 - 5
Restoration of functional network state towards more physiological condition as the correlate of clinical effects of pallidal deep brain stimulation in dystonia.
Filip P, Jech R, Fečíková A, et al.
Brain stimulation 2022; (15(5)):1269-1278 doi:10.1016/j.brs.2022.08.025.
PMID: 36096443 - 6
Deep brain stimulation for pediatric dystonia: a meta-analysis with individual participant data.
Elkaim LM, Alotaibi NM, Sigal A, et al.
Developmental medicine and child neurology 2019; (61(1)):49-56 doi:10.1111/dmcn.14063.
PMID: 30320439 - 7
Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis.
Artusi CA, Dwivedi A, Romagnolo A, et al.
Journal of neurology, neurosurgery, and psychiatry 2020; (91(4)):426-433 doi:10.1136/jnnp-2019-322169.
PMID: 32079672 - 8
Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia.
Brüggemann N, Kühn A, Schneider SA, et al.
Neurology 2015; (84(9)):895-903 doi:10.1212/WNL.0000000000001312.
PMID: 25653290 - 9
Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis.
Moro E, LeReun C, Krauss JK, et al.
European journal of neurology 2017; (24(4)):552-560 doi:10.1111/ene.13255.
PMID: 28186378 - 10
Long-Term Globus Pallidus Internus Deep Brain Stimulation in Pediatric Non-Degenerative Dystonia: A Cohort Study and a Meta-Analysis.
Duga V, Giossi R, Romito LM, et al.
Movement disorders : official journal of the Movement Disorder Society 2024; (39(7)):1131-1144 doi:10.1002/mds.29815.
PMID: 38646731 - 11
GPi-DBS for KMT2B-Associated Dystonia: Systematic Review and Meta-Analysis.
Rajan R, Garg K, Saini A, et al.
Movement disorders clinical practice 2022; (9(1)):31-37 doi:10.1002/mdc3.13374.
PMID: 35005062 - 12
Surgical Complications of Deep Brain Stimulation in Children Across Targets and Indications: Multicenter Analysis of the CHILD-DBS Registry.
Balachandar A, Verhey LH, Mithani K, et al.
Neurology 2025; (105(9)):e214201 doi:10.1212/WNL.0000000000214201.
PMID: 41071966 - 13
Elective and Emergency Deep Brain Stimulation in Refractory Pediatric Monogenetic Movement Disorders Presenting with Dystonia: Current Practice Illustrated by Two Cases.
Garofalo M, Beudel M, Dijk JM, et al.
Neuropediatrics 2023; (54(1)):44-52 doi:10.1055/a-1959-9088.
PMID: 36223877 - 14
Deep Brain Stimulation for Pediatric Dystonia: A Review of the Literature and Suggested Programming Algorithm.
Gelineau-Morel R, Kruer MC, Garris JF, et al.
Journal of child neurology 2022; (37(10-11)):813-824 doi:10.1177/08830738221115248.
PMID: 36053123 - 15
Resting-State Pallidal-Cortical Oscillatory Couplings in Patients With Predominant Phasic and Tonic Dystonia.
Yokochi F, Kato K, Iwamuro H, et al.
Frontiers in neurology 2018; (9()):375 doi:10.3389/fneur.2018.00375.
PMID: 29904367 - 16
Deep brain stimulation in animal models of dystonia.
Perl S, Lüttig A, Köhling R, Richter A
Neurobiology of disease 2022; (175()):105912 doi:10.1016/j.nbd.2022.105912.
PMID: 36307031
This page explains DBS and surgery for early-onset generalized dystonia for informational purposes only and does not constitute medical advice. Discuss candidacy, risks, and expected outcomes with your child’s movement-disorder and neurosurgery team.